News & Updates
Filter by Specialty:
Show Multimedia Only

SGLT2 inhibitors easy on the kidneys of Asians with T2D
22 Mar 2025
byJairia Dela Cruz
Among Asians with type 2 diabetes (T2D), users of sodium-glucose cotransporter-2 (SGLT2) inhibitors may have better kidney outcomes compared with those who use other glucose-lowering drugs.
SGLT2 inhibitors easy on the kidneys of Asians with T2D
22 Mar 2025
Ensitrelvir safe, effective in preventing COVID-19 in households
21 Mar 2025
byStephen Padilla
Treatment with ensitrelvir among household contacts (HHC) of index patients (IP) with COVID-19 within 72 h after the onset of IP symptoms demonstrates efficacy and an acceptable safety profile as postexposure prophylaxis (PEP) in SCORPIO-PEP, a phase III placebo-controlled trial.